31 results on '"Cotte Laurent"'
Search Results
2. Evaluation of drug abuse by hair analysis and self-reported use among MSM under PrEP: Results from a French sub-study of the ANRS-IPERGAY trial.
3. COVID-19 attack rate in HIV-infected patients and in PrEP users
4. Evaluation of Drug Abuse by Hair Analysis and Self-Reported Use Among MSM Under PrEP: Results From a French Substudy of the ANRS-IPERGAY Trial
5. Coronavirus disease 2019 attack rate in HIV-infected patients and in preexposure prophylaxis users
6. Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infection
7. Early diagnosis and risk factors of acute hepatitis C in high-risk MSM on preexposure prophylaxis
8. Drug resistance among patients who acquired HIV infection in a PrEP trial
9. Drug resistance among patients who acquired HIV infection in a preexposure prophylaxis trial
10. Costs and benefits of on-demand HIV preexposure prophylaxis in MSM
11. Smoking‐associated morbidities on computed tomography lung cancer screens in HIV‐infected smokers
12. Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohort
13. Initiation of Antiretroviral Therapy Containing Integrase Inhibitors Increases the Risk of IRIS Requiring Hospitalization
14. Sub-Saharan African migrants have slower initial CD4+ cell recovery after combined antiretroviral treatment initiation than French natives
15. Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study
16. Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study
17. Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV–hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy
18. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
19. Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4)
20. Is impaired kidney function an independent predictor of the risk of myocardial infarction in HIV-infected individuals?
21. Comparison of renal changes with lopinavir/ritonavir plus raltegravir or tenofovir/emtricitabine in the PROGRESS study
22. Discordance in HIV-1 Co-Receptor Use Prediction by Different Genotypic Algorithms and Phenotype Assay: Intermediate Profile in Relation to Concordant Predictions
23. Impact of Individual Antiretroviral Drugs on the Risk of Myocardial Infarction in Human Immunodeficiency Virus–Infected Patients: A Case-Control Study Nested Within the French Hospital Database on HIV ANRS Cohort CO4
24. Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population
25. Prediction of the Virological Response to Etravirine in Clinical Practice: Comparison of Three Genotype Algorithms
26. Population Pharmacokinetics of Tenofovir in AIDS Patients
27. Expected response to protease inhibitors of HIV-1 non-B subtype viruses according to resistance algorithms
28. Treatment response to ritonavir-boosted tipranavir versus ritonavir-boosted lopinavir in HIV-1 patients with higher lopinavir mutation scores
29. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men
30. Trial of oral fumagillin for the treatment of intestinal microsporidiosis in patients with HIV infection
31. Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.